Form 4 for CTVA Corteva
Accepted 2025-09-02 00:00:00 ET · period of report 2025-08-29 · accession 0000950170-25-112563 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-09-02 | 2025-08-29 | CTVA | King Robert D. | EVP, Crop Protection Business | M - OptEx | $60.06 | +24.3K | 86.5K | +39% | +$1.46M |
| D | 2025-09-02 | 2025-08-29 | CTVA | King Robert D. | EVP, Crop Protection Business | S - Sale+OE | $74.20 | -37.3K | 49.3K | -43% | -$2.77M |
| DM | 2025-09-02 | 2025-08-29 | CTVA | King Robert D. | EVP, Crop Protection Business | M - OptEx | $0.00 | -24.3K | 4,669 | -84% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-29 | M | A | 14,960 | $58.67 | 77,179.91 | D | — | — | |
| 2 | Common | Common Stock | 2025-08-29 | M | A | 9,337 | $62.29 | 86,516.91 | D | — | — | |
| 3 | Common | Common Stock | 2025-08-29 | S | D | 37,280 | $74.20 | 49,262.29 | D | — | — | (F1) The price reported represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $74.17 to $74.23, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. (F2) Includes acquisition of 25.3808 shares pursuant to dividend reinvestment. |
| 4 | Derivative | Non-Qualified Stock Option (right-to-buy) | 2025-08-29 | M | D | 14,960 | $0.00 | 0 | D | $58.67 · — to 2032-04-04 | 14,960 Common Stock | (F3) The options became fully exercisable on April 4, 2025, the third anniversary of the grant date. |
| 5 | Derivative | Non-Qualified Stock Option (right-to-buy) | 2025-08-29 | M | D | 9,337 | $0.00 | 4,669 | D | $62.29 · — to 2033-02-28 | 9,337 Common Stock | (F4) One-third of the options became exercisable on February 28, 2024, an additional one-third of the options became exercisable on February 28, 2025, and the remaining one-third of the options will become exercisable on February 28, 2026, the third anniversary of the grant date. |